Dyne Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 CYTK
|
Cytokinetics, Incorporated | $49.10 | $6.05 B | -9.78 | 423 | $7.53 M |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.61 | $217.51 M | -3.7 | 54 | $0 |
 ERAS
|
Erasca, Inc. | $2.69 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $32.23 | $1.65 B | -11.47 | 108 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.49 | $243.38 M | -1.59 | 133 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.49 | $652.38 M | -6.03 | 28 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $12.96 | $672.63 M | -3.9 | 166 | $1.58 M |
 RVMD
|
Revolution Medicines, Inc. | $56.71 | $6.66 B | -10.51 | 490 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.44 | $774.50 M | -6.14 | 110 | $8.78 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |